We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TMDX market cap is 2.27B. The company's latest EPS is USD -0.7435 and P/E is -90.73.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.43M | 81.17M | 96.85M | 114.31M | 108.76M |
| Operating Income | -28.34M | 2.6M | 12.42M | 12.51M | 3.92M |
| Net Income | -25.42M | 4.03M | 12.2M | 12.19M | 4.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.6M | 25.64M | 30.26M | 93.46M | 241.62M |
| Operating Income | -29.6M | -26.38M | -39.43M | -31.44M | -28.73M |
| Net Income | -33.55M | -28.75M | -44.22M | -36.23M | -25.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 689.23M | 706.05M | 723.83M | 758.58M | 785.57M |
| Total Liabilities | 562.77M | 568.85M | 564.36M | 568.68M | 575.65M |
| Total Equity | 126.46M | 137.2M | 159.47M | 189.89M | 209.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 105.3M | 152.03M | 134.89M | 277.15M | 706.05M |
| Total Liabilities | 50.65M | 48.14M | 67.04M | 89.77M | 568.85M |
| Total Equity | 54.65M | 103.89M | 67.85M | 187.38M | 137.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.33M | -13.03M | -3.44M | 22.28M | 29.14M |
| Investing | -152.14M | -193.95M | -44.17M | -67.94M | -115.7M |
| Financing | 399.49M | 400.42M | 3.19M | 13.83M | 21.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.29M | -30.27M | -28.86M | -45.82M | -13.03M |
| Investing | -60.5M | -41.6M | 29.27M | 54.51M | -193.95M |
| Financing | 92.72M | 75.55M | 1.39M | 167.93M | 400.42M |
| Market Cap | 2.27B |
| Price to Earnings Ratio | -90.73 |
| Price to Sales Ratio | 9.4 |
| Price to Cash Ratio | 5.75 |
| Price to Book Ratio | 16.55 |
| Dividend Yield | - |
| Shares Outstanding | 33.66M |
| Average Volume (1 week) | 1.7M |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | -20.64% |
| 52 Week High | 177.37 |
| 52 Week Low | 55.00 |
| Spread (Intraday) | 18.9 (23.74%) |
| Company Name | TransMedics Group Inc |
| Address |
200 minuteman road andover, massachusetts 01810 |
| Website | https://www.transmedics.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
